Impact of different Sofosbuvir-based direct acting antiviral (DAA) regimen in elderly cirrhotic patients: A real world experience from CLEO Group
Titel:
Impact of different Sofosbuvir-based direct acting antiviral (DAA) regimen in elderly cirrhotic patients: A real world experience from CLEO Group
Auteur:
Pellicelli, A.M. Pace Palitti, V. Vignally, P. Moretti, A. Tarquini, P. Scifo, G. Messina, V. Ascione, A. Izzi, A. D’Ambrosio, C. Villani, R. Fondacaro, L. Fontanella, L. Guarascio, P. Alessio, L. Miglioresi, L. D’amico, E. Ettorre, G.M. Marignani, M. Begini, P. Cerasari, G. Barlattani, A. Armignacco, O. Barbarini, G.